Switzerland· 66256001
Mebucaïne N, Lutschtabletten
A cetylpyridinium product containing cetylpyridinii chloridum, lidocaini hydrochloridum monohydricum, registered in Switzerland by Spirig HealthCare AG and dispensed under Swissmedic category D. The same ATC class is registered in 4 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Cetylpyridinium is registered in 4 of 19 countries.
Countries holding a registration under ATC R02AA06 (cetylpyridinium), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 3 of them publish a price we can compare per daily dose
Cetylpyridinium · ATC R02AA06
4 / 19 countries
- Canada
- Czechiaprice
- Polandprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- cetylpyridinii chloridum, lidocaini hydrochloridum monohydricum
- Manufacturer
- Spirig HealthCare AG
- Country
- Switzerland (CH)
- ATC code
- R02AA06
- ATC class
- Cetylpyridinium
- Swissmedic category
- D
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for cetylpyridinium.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cetylpyridinium · interactions on record
1 record
- 1 moderate
Most severe, free to view
- Hyaluronic acidM09AX01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cetylpyridinium in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBonjela Junior gelReckitt Benckiser Healthcare (UK) Ltd
- PolandCalgelDelfarma Sp. z o.o.
- CzechiaCALGELMcNeil Healthcare (Ireland) Limited, Dublin
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Bulgaria · Калгел
- Czechia · Calgel
- Estonia · Calgel
- United Kingdom (Northern Ireland) · Bonjela Junior, Calgel Teething
- Greece · Xylojell Plus
- Hungary · Mebucain Mint
- Latvia · Calgel
- Poland · Calgel, Orofar Max
- Romania · Calgel
- Slovenia · Calgel
- Slovakia · Calgel, Oroforte Menthol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e68075b9-500c-421c-9d63-672f213b383b GET /v1/drugs/e68075b9-500c-421c-9d63-672f213b383b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about cetylpyridinium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.